Showing results (201-210 of 249) with videos related to

Sort By:
Pageof 25
International Journal of Cancer|January 8, 2003
Complete loss of HLA class I antigen expression on melanoma cells: a result of successive mutational eventsAnnette Paschen, Rosa María Méndez, Pilar Jimenez, et al.
Cancer Immunology, Immunotherapy : CII|September 28, 2004
Expression of MHC class I, MHC class II, and cancer germline antigens in neuroblastomaMatthias Wölfl, Achim A Jungbluth, Federico Garrido, et al.
Cancers|June 18, 2020
Restoration of MHC-I on Tumor Cells by Fhit Transfection Promotes Immune Rejection and Acts as an Individualized Immunotherapeutic VaccineMaría Pulido, Virginia Chamorro, Irene Romero, et al.
Cancer Immunology, Immunotherapy : CII|April 3, 2009
HLA and melanoma: multiple alterations in HLA class I and II expression in human melanoma cell lines from ESTDAB cell bankRosa Mendez, Natalia Aptsiauri, Ana Del Campo, et al.
Human Immunology|April 17, 2012
Association between C13ORF31, NOD2, RIPK2 and TLR10 polymorphisms and urothelial bladder cancerMacarena Guirado, Hernani Gil, Pablo Saenz-Lopez, et al.
Immunogenetics|July 20, 2004
Distribution of HLA class I altered phenotypes in colorectal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21Isabel Maleno, Carmen Maria Cabrera, Teresa Cabrera, et al.
International Journal of Cancer|September 30, 2004
Coordinated downregulation of the antigen presentation machinery and HLA class I/beta2-microglobulin complex is responsible for HLA-ABC loss in bladder cancerJose María Romero, Pilar Jiménez, Teresa Cabrera, et al.
Human Immunology|July 8, 2009
Changes in activatory and inhibitory natural killer (NK) receptors may induce progression to multiple myeloma: implications for tumor evasion of T and NK cellsMónica Bernal, Pilar Garrido, Pilar Jiménez, et al.
Cancers|October 23, 2021
Copy Neutral LOH Affecting the Entire Chromosome 6 Is a Frequent Mechanism of HLA Class I Alterations in CancerMaria Antonia Garrido, Francisco Perea, Jose Ramon Vilchez, et al.
Nature Communications|November 17, 2025
β-adrenergic signaling blockade attenuates metastasis through activation of cytotoxic CD4 T cellsKlaire Yixin Fjæstad, Astrid Zedlitz Johansen, Hannes Linder, et al.
Pageof 25